Resveratrol may improve osseointegration of dental implants in type 2 diabetes mellitus patients Sir, Diabetes mellitus refers to a number of metabolic disorders, which are caused by an increase in the level of fasting plasma glucose. Type 2 diabetes mellitus (T2DM) can aff ect the bone, which causes osteopenia and impairs the healing of fractures. [1] Dental implants have been recognized as an acceptable treatment method for the replacement of missing teeth. This treatment is highly related to bone mass. Any changes in the rates of formation and resorption that result in bone resorption over-stepping bone formation can cause a decrease in this mass resulting in implant failure, which is the case in T2DM patients. Diabetes has become the most common factor contributing to dental implants failure. [2] Resveratrol (RSV) is a phytoalexin present in grapes, wines and peanuts, It has been reported to exhibit a wide range of biological and pharmacological properties that regulates several metabolic pathways. [3] RSV has a direct eff ect on bone formation and increases osteogenesis. [4, 5] In addition RSV has anti-infl ammatory and analgesic eff ects. [6, 7] In T2DM patients, the rate of osseointegration around dental implant decreases remarkably due to negative eff ect on diff erent stages of osseointegration such as formation of bone matrix, bone apposition mineralization (through reduction of osteoblasts and alkaline phosphates activity) and maintenance of osseointegration. [8] Osteoblast maturation is assessed by these items including, alkaline phosphates activity, calcium deposition in the extracellular matrix, Osterix and Osteocalcin genes. RSV increases expression of these genes, which is associated with osteoblastic differentiation and also increases the expression of alkaline phosphates and prolyl hydroxylase in a dose-dependent manner. [9] It also enhances the diff erentiation of osteoblasts from mesenchymal stem cells. [4] RSV is a potent inhibitor of inflammatory molecules and has an inhibitory eff ect on the production of tumor necrosis factor α, IL-1, IL-6, IL-12 and Interferon (IFN) by macrophages and splenic lymphocytes. [10] LETTER TO EDITOR
